Global Cellular Immunotherapy Market Size, Trends & Growth Opportunity, By Therapy Type (CAR T Cell Therapy, Dendritic Cell Therapy, NK Cell Therapy, TIL Therapy, Others), By Indication (B-cell Malignancies, Prostate Cancer, Liver Cancer, Renal Cell Carcinoma, Others), By End-use, and Forecast till 2027.
Global Cellular Immunotherapy Market
The Global Cellular Immunotherapy Market was valued at USD 7.5 billion in 2021 which expected to reach USD 37.97 billion by 2027 at a CAGR 22.41% from 2020-2027.
The Qualiket Research offers in-depth analysis, revenue details, and other important information regarding the Cellular Immunotherapy Market, and the various trends, drivers, restraints. A top-down & bottom-up approaches were employed in the preparation of the report on Cellular Immunotherapy Market. The overall report has been sectioned into an overview of the Cellular Immunotherapy Market, segmental outline, regional analysis, competitive dashboard, and the recent market updates. The Cellular Immunotherapy Market overview has been categorized into market statistics as well as the market highlights. Proficient analysts applied modern research methodologies for extensive primary & secondary research on the Cellular Immunotherapy Market.
The market statistics segment briefs on the forecasted CAGR the Cellular Immunotherapy Market is anticipated to register over the review period and the valuation it can attain by the end year. The market highlights details boosters and restraints, which can influence the target market growth over the forecast period. Skilled market analysts have meticulously worked on the evolution of the Cellular Immunotherapy Market and have identified the recent trends reinforcing the Cellular Immunotherapy Market growth. They have also spotted every opportunity based on that the market can capitalize
The market overview was noted on a zero-deviation approach & have maintained excellent quality research techniques throughout the Cellular Immunotherapy Market analysis. The segmental outline targets facets of the Cellular Immunotherapy Market. The regional analysis of the Cellular Immunotherapy Market provides an idea regarding the regional progress of the Cellular Immunotherapy Market as well as the identification of growth windows. In addition, the key vendors of the Cellular Immunotherapy Market have been segregated on a regional basis. Interviews with key people of the Cellular Immunotherapy Market and other credible sources like whitepaper are referred for designing the key operating players section. Furthermore, finally, the Cellular Immunotherapy Market update section mentions the recent key developments in the Cellular Immunotherapy Market
The report also helps in understanding Cellular Immunotherapy Market dynamics, structure by analyzing the market segments and projects the Cellular Immunotherapy Market. Overall representation of competitive analysis of key operating players by financial position, Product portfolio, growth strategies, as well as the regional presence in the Cellular Immunotherapy Market make the report investor’s guide.
Key Players:
The key players profiled in the Leavening Agents market report Bristol-Myers Squibb Company; Novartis AG; Gilead Sciences Inc. (Kite Pharma); F. Hoffmann-La Roche Ltd; Merck KGaA; GlaxoSmithKline plc.; AstraZeneca; Pfizer Inc.; Johnson & Johnson; Celyad, Adicet Bio, Inc.;
Market Taxonomy
By Therapy Type
CAR T Cell Therapy
Dendritic Cell Therapy
NK Cell Therapy
TIL Therapy
Others
By Indication
B-cell Malignancies
Prostate Cancer
Liver Cancer
Renal Cell Carcinoma
Others
By End-use
Hospitals
Cancer Institutes
Others
By Region
North America
Latin America
Europe
Asia Pacific
Middle East & Africa
- 1 Introduction
- 1.1 Objective of the Study
- 1.2 Market definition
- 1.3 Market Scope
- 2 Research Methodology
- 2.1 Data Mining
- 2.2 Validation
- 2.3 Primary Interviews
- 2.4 List of Data Sources
- 3 Executive Summary
- 4 Global Cellular Immunotherapy Market Outlook
- 4.1 Overview
- 4.2 Market Dynamics
- 4.2.1 Drivers
- 4.2.2 Restraints
- 4.2.3 Opportunities
- 4.3 Porters Five Force Model
- 4.4 Value Chain Analysis
- 5 Global Cellular Immunotherapy Market, By Therapy Type
- 5.1 Y-o-Y Growth Comparison, By Therapy Type
- 5.2 Global Cellular Immunotherapy Market Share Analysis, By Therapy Type
- 5.3 Global Cellular Immunotherapy Market Size and Forecast, By Therapy Type
- 5.3.1 CAR T Cell Therapy
- 5.3.2 Dendritic Cell Therapy
- 5.3.3 NK Cell Therapy
- 5.3.4 TIL Therapy
- 5.3.5 Others
- 6 Global Cellular Immunotherapy Market, By Indication
- 6.1 Y-o-Y Growth Comparison, By Indication
- 6.2 Global Cellular Immunotherapy Market Share Analysis, By Indication
- 6.3 Global Cellular Immunotherapy Market Size and Forecast, By Indication
- 6.3.1 B-cell Malignancies
- 6.3.2 Prostate Cancer
- 6.3.3 Liver Cancer
- 6.3.4 Renal Cell Carcinoma
- 6.3.5 Others
- 7 Global Cellular Immunotherapy Market, By End-use
- 7.1 Y-o-Y Growth Comparison, By End-use
- 7.2 Global Cellular Immunotherapy Market Share Analysis, By End-use
- 7.3 Global Cellular Immunotherapy Market Size and Forecast, By End-use
- 7.3.1 Hospitals
- 7.3.2 Cancer Institutes
- 7.3.3 Others
- 8 Global Cellular Immunotherapy Market, By Region
- 8.1 Global Cellular Immunotherapy Market Share Analysis, By Region
- 8.2 Global Cellular Immunotherapy Market Share Analysis, By Region
- 8.3 Global Cellular Immunotherapy Market Size and Forecast, By Region
- 9 North America Cellular Immunotherapy Market Analysis and Forecast (2022-2027)
- 9.1 Introduction
- 9.2 North America Cellular Immunotherapy Market Share Analysis, By Therapy Type
- 9.3 North America Cellular Immunotherapy Market Size and Forecast, By Indication
- 9.4 North America Cellular Immunotherapy Market Size and Forecast, By End-use
- 9.6 North America Cellular Immunotherapy Market Size and Forecast, By Country
- 9.6.1 U.S.
- 9.6.2 Canada
- 9.6.3 Mexico
- 10 Europe Cellular Immunotherapy Market Analysis and Forecast (2022-2027)
- 10.1 Introduction
- 10.2 Europe Cellular Immunotherapy Market Share Analysis, By Therapy Type
- 10.3 Europe Cellular Immunotherapy Market Size and Forecast, By Indication
- 10.4 Europe Cellular Immunotherapy Market Size and Forecast, By End-use
- 10.6 Europe Cellular Immunotherapy Market Size and Forecast, By Country
- 10.6.1 Germany
- 10.6.2 France
- 10.6.3 UK
- 10.6.4. Rest of Europe
- 11 Asia Pacific Cellular Immunotherapy Market Analysis and Forecast (2022-2027)
- 11.1 Introduction
- 11.2 Asia Pacific Cellular Immunotherapy Market Share Analysis, By Therapy Type
- 11.3 Asia Pacific Cellular Immunotherapy Market Size and Forecast, By Indication
- 11.4 Asia Pacific Cellular Immunotherapy Market Size and Forecast, By End-use
- 11.6 Asia Pacific Cellular Immunotherapy Market Size and Forecast, By Country
- 11.6.1 China
- 11.6.2 Japan
- 11.6.3 India
- 11.6.4. Rest of Asia Pacific
- 12 Latin America Cellular Immunotherapy Market Analysis and Forecast (2022-2027)
- 12.1 Introduction
- 12.2 Latin America Cellular Immunotherapy Market Share Analysis, By Therapy Type
- 12.3 Latin America Cellular Immunotherapy Market Size and Forecast, By Indication
- 12.4 Latin America Cellular Immunotherapy Market Size and Forecast, By End-use
- 12.6 Latin America Cellular Immunotherapy Market Size and Forecast, Country
- 12.6.1. Brazil
- 12.6.2. Rest of Latin America
- 13 Middle East Cellular Immunotherapy Market Analysis and Forecast (2022-2027)
- 13.1 Introduction
- 13.2 Middle East Cellular Immunotherapy Market Share Analysis, By Therapy Type
- 13.3 Middle East Cellular Immunotherapy Market Size and Forecast, By Indication
- 13.4 Middle East Cellular Immunotherapy Market Size and Forecast, By End-use
- 13.6 Middle East Cellular Immunotherapy Market Size and Forecast, By Country
- 13.6.1. Saudi Arabia
- 13.6.2. UAE
- 13.6.3. Egypt
- 13.6.4. Kuwait
- 13.6.5. South Africa
- 14 Competitive Analysis
- 14.1 Competition Dashboard
- 14.2 Market share Analysis of Top Vendors
- 14.3 Key Development Strategies
- 15 Company Profiles
- 15.1 Bristol-Myers Squibb Company
- 15.1.1 Overview
- 15.1.2 Therapy Types
- 15.1.3 Key Financials
- 15.1.4 Business Segment & Geographic Overview
- 15.1.5 Key Market Developments
- 15.1.6 Key Strategies
- 15.2. Novartis AG
- 15.2.1 Overview
- 15.2.2 Therapy Types
- 15.2.3 Key Financials
- 15.2.4 Business Segment & Geographic Overview
- 15.2.5 Key Market Developments
- 15.2.6 Key Strategies
- 15.3. Gilead Sciences Inc.
- 15.3.1 Overview
- 15.3.2 Therapy Types
- 15.3.3 Key Financials
- 15.3.4 Business Segment & Geographic Overview
- 15.3.5 Key Market Developments
- 15.3.6 Key Strategies
- 15.4 F. Hoffmann-La Roche Ltd
- 15.4.1 Overview
- 15.4.2 Therapy Types
- 15.4.3 Key Financials
- 15.4.4 Business Segment & Geographic Overview
- 15.4.5 Key Market Developments
- 15.4.6 Key Strategies
- 15.5 Merck KGaA
- 15.5.1 Overview
- 15.5.2 Therapy Types
- 15.5.3 Key Financials
- 15.5.4 Business Segment & Geographic Overview
- 15.5.5 Key Market Developments
- 15.5.6 Key Strategies
- 15.6 GlaxoSmithKline plc
- 15.6.1 Overview
- 15.6.2 Therapy Types
- 15.6.3 Key Financials
- 15.6.4 Business Segment & Geographic Overview
- 15.6.5 Key Market Developments
- 15.6.6 Key Strategies
- 15.7 AstraZeneca
- 15.7.1 Overview
- 15.7.2 Therapy Types
- 15.7.3 Key Financials
- 15.7.4 Business Segment & Geographic Overview
- 15.7.5 Key Market Developments
- 15.7.6 Key Strategies
- 15.8 Pfizer Inc.
- 15.8.1 Overview
- 15.8.2 Therapy Types
- 15.8.3 Key Financials
- 15.8.4 Business Segment & Geographic Overview
- 15.8.5 Key Market Developments
- 15.8.6 Key Strategies
- 15.9 Johnson & Johnson
- 15.9.1 Overview
- 15.9.2 Therapy Types
- 15.9.3 Key Financials
- 15.9.4 Business Segment & Geographic Overview
- 15.9.5 Key Market Developments
- 15.9.6 Key Strategies
- 15.10 Celyad, Adicet Bio, Inc.
- 15.10.1 Overview
- 15.10.2 Therapy Types
- 15.10.3 Key Financials
- 15.10.4 Business Segment & Geographic Overview
- 15.10.5 Key Market Developments
- 15.10.6 Key Strategies
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook